Back to Search
JOSEPH FRIEDMAN, MD
Psychiatry Physician
NPI: 1003980418Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
194791(NY)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
1
With Results
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
NCT00488163COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
NCT00158223COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
The Effect of Rasagiline on Cognition in Parkinson's Disease
NCT01382342COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
PMID 21346734·Neuropsychopharmacology·2011
2-rct
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
PMID 12431845·Neuropsychopharmacology·2002
7-preclinical
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.
PMID 18558643·Am J Psychiatry·2008
8-other
A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia.
PMID 18204342·J Clin Psychopharmacol·2008
2-rct
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.
PMID 17646849·Mol Psychiatry·2008
8-other
Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet.
PMID 16149086·Mov Disord·2006
5-case
A randomized clinical trial of valacyclovir in multiple sclerosis.
PMID 15957509·Mult Scler·2005
3-trial
The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.
PMID 15876902·J Clin Psychopharmacol·2005
3-trial
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.
PMID 15205878·Psychopharmacology (Berl)·2004
6-review
Potential noradrenergic targets for cognitive enhancement in schizophrenia.
PMID 15115947·CNS Spectr·2004
6-review
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
PMID 11904128·Biol Psychiatry·2002
3-trial
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.
PMID 12153833·Am J Psychiatry·2002
4-observational
Aharonov-Casher-effect suppression of macroscopic tunneling of magnetic flux.
PMID 11863708·Phys Rev Lett·2002
8-other
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
PMID 11532729·Am J Psychiatry·2001
4-observational
Guanfacine treatment of cognitive impairment in schizophrenia.
PMID 11522468·Neuropsychopharmacology·2001
3-trial
Clinical and laboratory assessment of dehydration severity in children with acute gastroenteritis.
PMID 19487761·Clin Pediatr (Phila)·2010
8-other
A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease.
PMID 18931006·J Neurol Neurosurg Psychiatry·2009
4-observational
Naproxen-induced anemia and hypoalbuminemia in a 16-month-old child.
PMID 18632553·Clin Pediatr (Phila)·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 998 CROOKED HILL ROAD, PILGRIM PSYCHIATRIC CENTER BUILDING 47 THIRD FLOOR
W BRENTWOOD, NY 11717 - Phone
- (631) 761-3607
Quick Facts
- NPI
- 1003980418
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile